OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oxidative stress as a culprit in diabetic kidney disease
Sensen Su, Zhanchuan Ma, Hao Wu, et al.
Life Sciences (2023) Vol. 322, pp. 121661-121661
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The roles of gut microbiota and its metabolites in diabetic nephropathy
Hui Zhao, Cheng-E Yang, Tian Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 25

Osthole ameliorates early diabetic kidney damage by suppressing oxidative stress, inflammation and inhibiting TGF-β1/Smads signaling pathway
Qiangsheng Li, Yifei Wang, Yan Jia, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112131-112131
Closed Access | Times Cited: 5

Global research hotspots and trends in oxidative stress-related diabetic nephropathy: a bibliometric study
Xiaorong Wang, Wu Zeng, Tingchao He, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access

The Role and Mechanism of Gut Microbiota in the Development of Diabetic Nephropathy
梅 韩
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 215-222
Closed Access

Clinical metabolomics in type 2 diabetes mellitus: from pathogenesis to biomarkers
Chuanxin Liu, Haoqiang Chen, Yujin Ma, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access

Mangiferin promotes porcine oocyte maturation and delays the postovulatory aging process by up-regulating NRF2 levels
Xiu‐Wen Yuan, Hongchao Ji, Yuhao Zhang, et al.
Theriogenology (2025) Vol. 239, pp. 117384-117384
Closed Access

MicroRNA-204-5p Ameliorates Renal Injury via Regulating Keap1/Nrf2 Pathway in Diabetic Kidney Disease
Jiajia Dong, Mengyu Liu, Yawei Bian, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 75-92
Open Access | Times Cited: 4

PDK4-mediated Nrf2 inactivation contributes to oxidative stress and diabetic kidney injury
Shasha Tian, Xiaopeng Yang, Yao Lin, et al.
Cellular Signalling (2024) Vol. 121, pp. 111282-111282
Closed Access | Times Cited: 4

Dang-Gui-Bu-Xue decoction against diabetic nephropathy via modulating the carbonyl compounds metabolic profile and AGEs/RAGE pathway
Zhi‐Tong Zhang, Yali Qi, Pan Chen, et al.
Phytomedicine (2024) Vol. 135, pp. 156104-156104
Closed Access | Times Cited: 4

The therapeutic effects of marine sulfated polysaccharides on diabetic nephropathy
Lijuan Wu, Xiaonan Zhang, Jun Zhao, et al.
International Journal of Biological Macromolecules (2024) Vol. 261, pp. 129269-129269
Closed Access | Times Cited: 3

β-cryptoxanthin suppresses oxidative stress via activation of the Nrf2/HO-1 signaling pathway in diabetic kidney disease
Jingjing Ke, Hualong Zang, Yang Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3

Modified Hu-lu-ba-wan protects diabetic glomerular podocytes via promoting PKM2-mediated mitochondrial dynamic homeostasis
Minmin Gong, Yujin Guo, Hui Dong, et al.
Phytomedicine (2023) Vol. 123, pp. 155247-155247
Open Access | Times Cited: 8

Naringenin – a potential nephroprotective agent for diabetic kidney disease: A comprehensive review of scientific evidence
Estefania Valle-Velázquez, Oscar René Zambrano-Vásquez, Fernando Cortés-Camacho, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 6, pp. 1441-1451
Open Access | Times Cited: 2

Clinical Use and Treatment Mechanism of Molecular Hydrogen in the Treatment of Various Kidney Diseases including Diabetic Kidney Disease
Shin‐ichi Hirano, Yusuke Ichikawa, Bunpei Sato, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2817-2817
Open Access | Times Cited: 6

Novel pharmacological interventions for diabetic kidney disease
Seng Kiong Tan, Jairo A Pinzón-Cortés, Mark E. Cooper
Current Opinion in Nephrology & Hypertension (2023) Vol. 33, Iss. 1, pp. 13-25
Closed Access | Times Cited: 5

8-hydroxy-2′-deoxyguanosine, a biomarker of oxidative DNA injury, in diabetic kidney disease
Belinda Spoto, Cristina Politi, Patrizia Pizzini, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 35, Iss. 2, pp. 103722-103722
Closed Access

Mechanism of metabolic memory: progression in diabetic nephropathy—a descriptive review
Farhana Begum, Karpagavel Lakshmanan
Egyptian Journal of Medical Human Genetics (2024) Vol. 25, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top